ArticleCell reports. Medicine2023

Entrectinib inhibits NLRP3 inflammasome and inflammatory diseases by directly targeting NEK7.

Xiangyu Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.